LENZ Therapeutics, Inc. (LENZ) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $305.88M | +42.1% |
| 2024 | $215.30M | +205.9% |
| 2023 | $70.38M | -78.1% |
| 2022 | $321.90M | -19.9% |
| 2021 | $401.99M | +1681.5% |
| 2020 | $22.56M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $305.88M | +42.1% |
| 2024 | $215.30M | +205.9% |
| 2023 | $70.38M | -78.1% |
| 2022 | $321.90M | -19.9% |
| 2021 | $401.99M | +1681.5% |
| 2020 | $22.56M | — |